Pfizer Doubles Profit on Strong International Sales

July 23, 2008
Pharmaceutical firm reaffirms 2008 outlook.

U.S. pharmaceuticals giant Pfizer said Wednesday its second-quarter net profit more than doubled due to surging international sales and reaffirmed its 2008 outlook. Net profit in the April-June period was $2.776 billion, a whopping 119% higher than a year ago, or 41 cents per share. Excluding exceptional items, earnings per share were 55 cents, slightly better than analysts' consensus forecast of 54 cents. Revenue rose 9% to $12.1 billion from the same period in 2007, led by international sales underpinned by a weak dollar, the company said. "Revenues reflect the positive impact of foreign exchange, which increased revenues by approximately $800 million, or 7%, as well as the solid performance of many key products," the company said. Sales abroad leaped 18% from a year ago, more than offsetting a 2% decline in the United States, and represented 61% of the group's total revenue. Sales of Pfizer's blockbuster anti-cholesterol drug Lipitor rose 9% to $3 billion. The company said the domestic revenue declines were mainly due to the loss of U.S. exclusivity for Zyrtec, an allergy medication it ceased selling in late January 2008, and for colorectal-cancer drug Camptosar, which it stopped selling in February 2008. Pfizer said other factors contributing to the strong quarterly performance included lower restructuring charges from cost-reduction initiatives and the savings generated by those initiatives, as well as income tax adjustments. The company confirmed its outlook for the 2008 full year: sales between $47 billion and $49 billion and earnings per share between $1.73 and $1.88. Copyright Agence France-Presse, 2008

Popular Sponsored Recommendations

How Manufacturers Can Optimize Operations with Weather Intelligence

Nov. 2, 2023
The bad news? Severe weather has emerged as one of the biggest threats to continuity and safety in manufacturing. The good news? The intelligence solutions that build weather ...

Ecommerce Guide: How to Manage Order Volume Spikes

Oct. 2, 2023
Master the art of delivering a seamless ecommerce shopping experience! Learn how to streamline your operations to successfully manage seasonal sales order spikes.

Discrete and Process Manufacturing 2024 Trends and Outlook for North America

Oct. 29, 2023
Manufacturers are reaping the benefits of automation and cloud-based solutions. Discover what is driving today's industry trends and how they can shape your growth priorities ...

How to Build Zero-Cost On-Site Solar and Storage Projects

Nov. 25, 2023
The Inflation Reduction Act offers tax credits, incentives, and financing that enable no-cost projects. In Enel’s eBook, discover the critical role that incentives play in your...

Voice your opinion!

To join the conversation, and become an exclusive member of IndustryWeek, create an account today!